Risk Factors for Graft Rejection Following Endothelial Keratoplasty: Focus on Cystoid Macular Edema
Authors:
Open Access
- 13 April 2026
- journal article
- Published by Wolters Kluwer Health in Cornea
Abstract
Purpose: The aim of this study was to investigate risk factors of immunologic graft rejection following endothelial keratoplasty, with a focus on cystoid macular edema (CMO). Methods: This is a single-center retrospective case review study including eyes undergoing either Descemet membrane endothelial keratoplasty (DMEK) or Descemet stripping automated keratoplasty (DSAEK). Univariate and multivariate analyses were conducted to evaluate whether several predetermined risk factors could influence the incidence of graft rejection. Receiver operating characteristic curve analysis was performed to determine ideal cutoff points of continuous variables. The following risk factors were assessed: recipient age, sex, indication for surgery, type of keratoplasty, glaucoma, and development of CMO. Results: A total of 3546 eyes were included, with 731 undergoing DMEK and 2815 undergoing DSAEK. The mean follow-up duration was 49.5 ± 37.9 months (median = 36 months). The incidence of graft rejection was 2.9% for DMEK and 4.0% for DSAEK ( P = 0.150) and was significantly influenced by the patients’ age (odds ratio [OR] = 2.17, 95% confidence interval [CI], 1.46–3.24), the presence of glaucoma (OR = 2.28, 95% CI, 1.50–3.46), and postoperative occurrence of CMO (OR = 11.09, 95% CI, 6.58–18.70) (all P < 0.001). The mean interval between the onset of CMO and the occurrence of rejection was 11.5 ± 14.1 months, with a median of 6 months. Conclusions: Occurrence of CMO, as well as the presence of glaucoma and a recipient's age <71.5 years, seems to play a significant role in the development of endothelial graft rejection following endothelial keratoplasty. Further studies are indicated to investigate a possible immunologic link between CMO and endothelial graft rejection episodes.Keywords
This publication has 14 references indexed in Scilit:
- Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK)—a systematic review and meta-analysisEye, 2023
- Impact of early intensified postoperative corticosteroids on immune reaction rates after Descemet membrane endothelial keratoplasty (DMEK)Graefe's Archive for Clinical and Experimental Ophthalmology, 2021
- Risk Factors for Cystoid Macular Edema After Descemet Membrane Endothelial KeratoplastyCornea, 2019
- Incidence and Clinical Course of Immune Reactions after Descemet Membrane Endothelial KeratoplastyOphthalmology, 2017
- Descemet's Membrane Endothelial KeratoplastyOphthalmology, 2016
- Contact Lens-Assisted Pull-Through Technique for Delivery of Tri-Folded (Endothelium in) DMEK Grafts Minimizes Surgical Time and Cell LossOphthalmology, 2016
- Intensified Topical Steroids as Prophylaxis for Macular Edema After Posterior Lamellar Keratoplasty Combined With Cataract SurgeryAmerican Journal of Ophthalmology, 2016
- Ultrathin Descemet's Stripping Automated Endothelial Keratoplasty with the Microkeratome Double-Pass TechniqueOphthalmology, 2013
- Graft Rejection Following Descemet Stripping Automated Endothelial Keratoplasty: Features, Risk Factors, and OutcomesAmerican Journal of Ophthalmology, 2012
- Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factorsBritish Journal of Ophthalmology, 2008